FI20105991A - Adenovirusvektoreita ja menetelmiä ja käyttöjä niihin liittyen - Google Patents

Adenovirusvektoreita ja menetelmiä ja käyttöjä niihin liittyen Download PDF

Info

Publication number
FI20105991A
FI20105991A FI20105991A FI20105991A FI20105991A FI 20105991 A FI20105991 A FI 20105991A FI 20105991 A FI20105991 A FI 20105991A FI 20105991 A FI20105991 A FI 20105991A FI 20105991 A FI20105991 A FI 20105991A
Authority
FI
Finland
Prior art keywords
methods
adenoviral vectors
uses relating
relating
adenoviral
Prior art date
Application number
FI20105991A
Other languages
English (en)
Swedish (sv)
Other versions
FI20105991A0 (fi
FI124927B (fi
Inventor
Joao Dias
Cerullo Vincenzo
Akseli Hemminki
Sari Pesonen
Original Assignee
Oncos Therapeutics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncos Therapeutics Oy filed Critical Oncos Therapeutics Oy
Publication of FI20105991A0 publication Critical patent/FI20105991A0/fi
Priority to FI20105991A priority Critical patent/FI124927B/fi
Priority to BR112013006699A priority patent/BR112013006699A2/pt
Priority to KR1020137010377A priority patent/KR20130108371A/ko
Priority to RU2013118723/10A priority patent/RU2013118723A/ru
Priority to US13/825,852 priority patent/US20130243731A1/en
Priority to AU2011306845A priority patent/AU2011306845C1/en
Priority to SG2013019120A priority patent/SG189001A1/en
Priority to CA2812093A priority patent/CA2812093A1/en
Priority to JP2013529691A priority patent/JP2014500004A/ja
Priority to EP11770846.1A priority patent/EP2619312A1/en
Priority to CN2011800533195A priority patent/CN103221544A/zh
Priority to PCT/FI2011/050822 priority patent/WO2012038606A1/en
Publication of FI20105991A publication Critical patent/FI20105991A/fi
Priority to ZA2013/02429A priority patent/ZA201302429B/en
Application granted granted Critical
Publication of FI124927B publication Critical patent/FI124927B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI20105991A 2010-09-24 2010-09-24 Adenovirusvektoreita ja niihin liittyviä menetelmiä ja käyttöjä FI124927B (fi)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FI20105991A FI124927B (fi) 2010-09-24 2010-09-24 Adenovirusvektoreita ja niihin liittyviä menetelmiä ja käyttöjä
SG2013019120A SG189001A1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies
JP2013529691A JP2014500004A (ja) 2010-09-24 2011-09-23 抗ｃｔｌａ−４モノクローナル抗体をコードする腫瘍溶解性アデノウイルスベクター
RU2013118723/10A RU2013118723A (ru) 2010-09-24 2011-09-23 Онколитические аденовирусные векторы, кодирующие моноклональные антитела против ctla-4
US13/825,852 US20130243731A1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti-ctla-4 antibodies
AU2011306845A AU2011306845C1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti - CTLA - 4 antibodies
BR112013006699A BR112013006699A2 (pt) 2010-09-24 2011-09-23 vetor adenoviral oncolítico que codifica anticorpos anti-ctl4-4 monoclonais, célula e composição farmacêutica compreendendo o mesmo, método de produção de anticorpo monoclonal humano específico para ctla-4 em uma célula e uso do referido vetor adenoviral
CA2812093A CA2812093A1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies
KR1020137010377A KR20130108371A (ko) 2010-09-24 2011-09-23 단클론 항―ｃｔｌａ－４ 항체를 암호화하는 종양분해 아데노바이러스 벡터
EP11770846.1A EP2619312A1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies
CN2011800533195A CN103221544A (zh) 2010-09-24 2011-09-23 编码单克隆抗-ctla-4抗体的溶瘤腺病毒载体
PCT/FI2011/050822 WO2012038606A1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies
ZA2013/02429A ZA201302429B (en) 2010-09-24 2013-04-04 Oncolytic adenoviral vectors coding for monoclonal anti-ctla-4 antibodies

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20105991 2010-09-24
FI20105991A FI124927B (fi) 2010-09-24 2010-09-24 Adenovirusvektoreita ja niihin liittyviä menetelmiä ja käyttöjä

Publications (3)

Publication Number Publication Date
FI20105991A0 FI20105991A0 (fi) 2010-09-24
FI20105991A true FI20105991A (fi) 2012-03-25
FI124927B FI124927B (fi) 2015-03-31

Family

ID=42829720

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20105991A FI124927B (fi) 2010-09-24 2010-09-24 Adenovirusvektoreita ja niihin liittyviä menetelmiä ja käyttöjä

Country Status (1)

Country Link
FI (1) FI124927B (fi)

Also Published As

Publication number Publication date
FI20105991A0 (fi) 2010-09-24
FI124927B (fi) 2015-03-31

Similar Documents

Publication Publication Date Title
BR112012017441A2 (pt) compostos e métodos
DK2542600T3 (da) Vandige polyurethandispersioner
ZA201301862B (en) Oncolytic adenoviral vectors and methods and uses related thereof
BR112013017629A2 (pt) laminina-521 recombinante
DE112011100715T8 (de) Hardware-hilfs-thread
BR112012028556A2 (pt) Indóis
DE102011100241A8 (de) Nitridhalbleiterbauteil
CR20130111A (es) Triazina-oxidiazoles
DE10170954T8 (de) Mikrowellendruckgarer
DE102011117046A8 (de) Doppelkupplungswindungsgetriebe
DE112011101226A5 (de) Linearwegmesssystem
DE112011102080A5 (de) Kupplungszentralausrücker
DK2442899T3 (da) Rotorskive
DE102011002623A8 (de) Ventilsteuerzeitversteller
DE112011102711A5 (de) Hydrostataktor
DK2448659T3 (da) Rotorskive
DK2447426T3 (da) Vaske-WC
FR2964937B1 (fr) Triporteur et direction de triporteur
DE112010005518A5 (de) Dichtungsmanchette
DE102010038420A8 (de) Reinigungungsvorrichtung
BR112012021749A2 (pt) processos e compostos
DK2521486T3 (da) Palpometer
DE102010035554B8 (de) Fußtüröffner
CO6801789A2 (es) N-hetarilmetil pirazolilcarboxamidas
DE112011101796A5 (de) Redoxakkumulatoranlage

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 124927

Country of ref document: FI

Kind code of ref document: B

MM Patent lapsed